Home > Healthcare > Biotechnology > Biotechnology R&D > Reconstructed Skin Models Market

Reconstructed Skin Models Market Share

Report ID: GMI9294
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Reconstructed Skin Models Market Share

The reconstructed skin models industry is moderately fragmented due to the presence of established, medium-scale and small vendors. Established vendors mainly rely on their scale and investments. Product launches and collaborations are among the key strategic initiatives considered by established players to gain competitive edge in the market. Small scale vendors rely on low pricing strategies to compete with established players.

Reconstructed Skin Models Market Companies

Prominent players operating in the reconstructed skin models industry include:

AIVITA Biomedical, Inc.
BICO - THE BIO CONVERGENCE COMPANY
CELLnTEC
EPISKIN
Henkel AG & Co. KGaA
Japan Tissue Engineering Co., Ltd.
Mallinckrodt plc
STRATICELL
WEPREDIC Group (Biopredic International)
ZenBio, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global reconstructed skin models market size was valued at USD 37.1 million in 2023 and is anticipated to showcase growth at 14.6% CAGR from 2024 – 2032 owing to the increasing prevalence of skin disorders.

Reconstructed skin models industry from the skin irritation test segment generated USD 9.73 million in 2023, driven by the growing approvals from regulatory authorities, such as EU for reconstructed skin model-based skin irritation test as an alternative to in vivo skin irritation test.

Europe accounted for 37.4% of the reconstructed skin models market share in 2023 and is predicted to reach USD 44.9 million by 2032, owing to the presence of established players in the region.

AIVITA Biomedical, Inc., BICO - THE BIO CONVERGENCE COMPANY, CELLnTEC, EPISKIN, Henkel AG & Co. KGaA, Japan Tissue Engineering Co., Ltd., Mallinckrodt plc, STRATICELL, WEPREDIC Group (Biopredic International) and ZenBio, Inc.